DIAGNOSTICS:

Studies of routine prostate cancer screening suggest they don’t prevent deaths, but lead to overdetection and overtreatment.

There’s nothing quite like the cries of resistance a latex glove makes as it is pulled downward on a physician’s hand that ends with the startling snap as the doctor instructs the compliant patient to hop off the table, turn around, and bend over.

Read More

Wrecked ‘em? Damn Near Killed Him
Studies of routine prostate cancer screening suggest they don’t prevent deaths, but lead to overdetection and overtreatment.

April 01, 2011 - DANIEL S. LEVINE - Health - Diagnostics
Childhood obesity may be triggered by a viral infection.
Kids exposed to one strain of cold virus on average weighed nearly 50 pounds more than children who were not.

September 24, 2010 - DANIEL S. LEVINE - Health - Obesity
Playing Chicken
For high risk technologies, it may take years to reach a commercial deal and the companies that pursue them may need to rely on alternatives to venture financing to carry them there.

March 13, 2009 - DANIEL S. LEVINE - Business - Business Strategy
The Best Column You've Ever Read
Research shows expectations are important, after findings that a placebo work better when patients think it's an expensive drug.

March 12, 2008 - DANIEL S. LEVINE - Law/Policy - Healthcare Reform
YouTube for the Lab Set
Website JoVE.com seeks to make experiments more reproducible through videos in hopes of speeding drug discovery.

February 29, 2008 - DANIEL S. LEVINE - Tech/Innovation - Research
A Healthcare System that Doesn't Value Health
A letter from the publishers

January 08, 2008 - DAVID GOLLAHER AND G. STEVEN BURRILL - Health - Wellness
Fix-Me-Itis
A letter from the editor

January 03, 2008 - WILLIAM PATRICK - Health - Wellness
A Letter to My Wife, the Doctor
Some gentle advice to a physician about caring for a very special patient during flu season.

December 14, 2007 - DANIEL S. LEVINE - Health - Medical Practice
History Lessons
As government's role in healthcare grows, the controversy surrounding proposed plans may have less to do with who pays for it than who proposes it.

November 07, 2007 - DAVID GOLLAHER - Health - Healthcare Reform
Targeted Chemotherapy
Genentech looks to build a drug delivery platform with its monoclonal antibodies, and technology to link them to potent cancer drugs.

November 05, 2007 - DANIEL S. LEVINE - Business - Drug Development
Licensed to Cure
Southern Research Institute sees a role for itself in bridging the academic and corporate worlds.

September 26, 2007 - DANIEL S. LEVINE - Tech/Innovation - Research
Old Love
Study finds majority of elderly Americans remain sexually active as health, rather than age, is the limiting factor.

August 22, 2007 - DANIEL S. LEVINE - Society - Research
Beyond Steroids
World Anti-Doping Agency turns its attention to detecting illicit gene doping.

August 10, 2007 - DANIEL S. LEVINE - Society - Culture
Amgen Feeling Anemic
Reimbursement restrictions could trigger a wallop from private payers.

August 06, 2007 - DANIEL S. LEVINE - Law/Policy - Regulatory
A Modest Proposal
Two oncologists want to address the high cost of drugs with a glass of grapefruit juice and the pharmaceutical industry should worry.

July 16, 2007 - DANIEL S. LEVINE - Tech/Innovation - Medical Economics
Moore Problems
Sicko opens the debate on universal healthcare as election season approaches.

July 06, 2007 - DANIEL S. LEVINE - Health - Healthcare Reform
Hedge fund managers seek to spur innovation in cancer research through $1 million prize.

June 01, 2007 - DANIEL S. LEVINE - Health - Innovation
Going Postal on Medical Costs
The CEO of the largest mail-meter company is changing the face of healthcare.

May 09, 2007 - DANIEL S. LEVINE - Health - Healthcare Reform
Mixing Molecular Metaphors
Andrew von Eschenbach says the FDA needs to change.

May 07, 2007 - DANIEL S. LEVINE - Law/Policy - Regulatory